Literature DB >> 29075066

A Comparison Between MRIT2 and NT-ProBNP in Early Detection of Heart Diseases in Thalassemia Major Patients: A Cross-Sectional Study.

Kourosh Goudarzipour1, Parinaz Alizadeh1, Hesameddin Hoseini Tavassol1, Reyhaneh Kazemi1, Peyman Eshghi1, Saeed Mojtahedzadeh2.   

Abstract

One of the most common causes of mortality in major thalassemia is cardiac complications. Despite existence of several methods for diagnosis of cardiac complications in thalassemia, this sequel persists as a major problem in these patients. The aim of this study is to compare the level of serum NT-ProBNP and cardiac MRI T2* in early detection and treatment of cardiac disorders in beta thalassemia major patients. 35 major thalassemic patients on regular transfusion were selected in our center from 2013 to 2014. All of the patients were at least 8 years old. NT-ProBNP and MRIT2* analyses were carried out for these patients, and consequently the findings were compared together and analyzed. There is a strong correlation between NT-ProBNP and MRIT2* (p value < 0.001) in early detection of cardiac disorders. NT-ProBNP is an important marker for diagnosis of cardiac complications before emergence of heart failure in thalassemic patients. Given the findings of this study, it is recommended that this marker be used on a regular basis for thalassemic patients on regular transfusion.

Entities:  

Keywords:  Heart failure; Iron overload; Major thalassemia; NT-ProBNP; T2* MRI

Year:  2017        PMID: 29075066      PMCID: PMC5640548          DOI: 10.1007/s12288-017-0797-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

Review 1.  The beta-thalassemias.

Authors:  N F Olivieri
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

2.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

3.  Diagnosis and management of transfusion iron overload: the role of imaging.

Authors:  John C Wood
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

4.  The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.

Authors:  Selen Bayraktaroğlu; Yeşim Aydinok; Dilek Yildiz; Hatice Uluer; Recep Savaş; Hüdaver Alper
Journal:  Diagn Interv Radiol       Date:  2011-06-06       Impact factor: 2.630

5.  NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients.

Authors:  Dimitrios Th Kremastinos; Dimitrios P Tsiapras; Anna G Kostopoulou; Eftihia S Hamodraka; Antigoni S Chaidaroglou; Evangelia D Kapsali
Journal:  Eur J Heart Fail       Date:  2007-02-21       Impact factor: 15.534

6.  Cardiac disease in beta-thalassaemia major: Is it reversible?

Authors:  M Atiq; M Bana; U S Ahmed; S Bano; M Yousuf; Z Fadoo; M Khurshid
Journal:  Singapore Med J       Date:  2006-08       Impact factor: 1.858

7.  Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.

Authors:  Hussain Isma'eel; Abdul Hamid El Chafic; Fuad El Rassi; Adlette Inati; Susan Koussa; Rose Daher; Walid Gharzuddin; Samir Alam; Ali Taher
Journal:  Am J Cardiol       Date:  2008-05-29       Impact factor: 2.778

8.  Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Authors:  Dimitrios Th Kremastinos; Eftihia Hamodraka; John Parissis; Dimitrios Tsiapras; Kleanthi Dima; Alan Maisel
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

9.  Tissue doppler imaging and NT-proBNP levels show the early impairment of ventricular function in patients with beta-thalassaemia major.

Authors:  Onur Akpinar; Esmeray Acartürk; Mehmet Kanadaşi; Cağatay Unsal; Fikri Başlamişli
Journal:  Acta Cardiol       Date:  2007-06       Impact factor: 1.718

10.  Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

Authors:  Mark A Tanner; Renzo Galanello; Carlo Dessi; Gillian C Smith; Mark A Westwood; Annalisa Agus; Martina Pibiri; Sunil V Nair; J Malcolm Walker; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-02-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.